EUVIMEDEUVIMED entdecken
Crossref

Downregulation of C1R promotes hepatocellular carcinoma development by activating HIF‐1α‐regulated glycolysis

Yuying Ma, Yuehua Wang, Peng Tuo, Zhongji Meng, Bin Jiang, Yahong Yuan, Yan Ding, Abid Naeem, Xingrong Guo, Xiaoli Wang iD

Molecular Carcinogenesis · 2024-11 · 63 (11) · 2237-2253

DOI: 10.1002/mc.23806 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Carcinogenesis, online erschienen am 16.08.2024. Verfasst von Yuying Ma und 9 weiteren Autor:innen. Beteiligte Einrichtung: Hubei Key Laboratory of Embryonic Stem Cell Research, Hubei Clinical Research Center for Umbilical Cord Blood Hematopoietic Stem Cells, School of Bas…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Glycolysis, Hypoxia-Inducible Factor 1, alpha Subunit. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: The Project of Creative Research Groups of Hubei Province, Department of Education Cultivating Project for Young Scholars at Hubei University of Medicine, The Natural Science Foundation of Hubei province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

C1R has been identified to have a distinct function in cutaneous squamous cell carcinoma that goes beyond its role in the complement system. However, it is currently unknown whether C1R is involved in the progression of hepatocellular carcinoma (HCC). HCC tissues were used to examine C1R expression in relation to clinical and pathological factors. Malignant characteristics of HCC cells were assessed through in vitro and in vivo experiments. The mechanism underlying the role of C1R in HCC was explored through RNA‐seq, methylation‐specific PCR, immuno‐precipitation, and dual‐luciferase reporter assays. This study found that the expression of C1R decreased as the malignancy of HCC increased and was associated with poor prognosis. C1R promoter was highly methylated through DNMT1 and DNMT3a, resulting in a decrease in C1R expression. Downregulation of C1R expression resulted in heightened malignant characteristics of HCC cells through the activation of HIF‐1α‐mediated glycolysis. Additionally, decreased C1R expression was found to promote xenograft tumor formation. We found that C‐reactive protein (CRP) binds to C1R, and the free CRP activates the NF‐κB signaling pathway, which in turn boosts the expression of HIF‐1α. This increase in HIF‐1α leads to higher glycolysis levels, ultimately promoting aggressive behavior in HCC. Methylation of the C1R promoter region results in the downregulation of C1R expression in HCC. C1R inhibits aggressive behavior in HCC in vitro and in vivo by inhibiting HIF‐1α‐regulated glycolysis. These findings indicate that C1R acts as a tumor suppressor gene during HCC progression, opening up new possibilities for innovative therapeutic approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsGlycolysisHypoxia-Inducible Factor 1, alpha SubunitGene Expression Regulation, NeoplasticDown-RegulationDNA MethylationHumansAnimalsMicePromoter Regions, GeneticMaleCell Line, TumorMice, NudeFemalePrognosisCell ProliferationC-Reactive ProteinSignal TransductionDNA Methyltransferase 3AMice, Inbred BALB C

Stichwörter der Autor:innen

C1RHIF‐1αglycolysishepatocellular carcinomamethylation

Substanzen

Hypoxia-Inducible Factor 1, alpha SubunitHIF1A protein, humanC-Reactive ProteinDNA Methyltransferase 3A

Autor:innen und Institutionen

  • Hubei Key Laboratory of Embryonic Stem Cell Research, Hubei Clinical Research Center for Umbilical Cord Blood Hematopoietic Stem Cells, School of Basic Medical Sciences, Taihe Hospital, Hubei University of Medicine, Shi…
  • Department of Infectious Diseases, Institute of Biomedical Research, Hubei Clinical Research Center for Precise Diagnosis and Treatment of Liver Cancer, Taihe Hospital, Shiyan, China.
  • Department of Hepatobiliary Pancreatic Surgery, Taihe Hospital, Shiyan, China.
  • School of Life Science, Advanced Research Institute of Multidisciplinary Science, School of Medical Technology, Key Laboratory of Molecular Medicine and Biotherapy, Key Laboratory of Medical Molecule Science and Pharmac…

ORCID-Profile: Xiaoli Wang

Förderung

  • The Project of Creative Research Groups of Hubei Province
  • Department of Education Cultivating Project for Young Scholars at Hubei University of Medicine
  • The Natural Science Foundation of Hubei province
  • The Key Projects of Hubei Education
  • The National Natural Science Foundation of China
  • the Innovative Research Program for Graduates of Hubei University of Medicine

Zitieren

APA

Ma, Y., Wang, Y., Tuo, P., Meng, Z., Jiang, B., Yuan, Y., Ding, Y., Naeem, A., Guo, X., & Wang, X. (2024). Downregulation of C1R promotes hepatocellular carcinoma development by activating HIF‐1α‐regulated glycolysis. Molecular Carcinogenesis, 63(11), 2237-2253. https://doi.org/10.1002/mc.23806

Vancouver

Ma Y, Wang Y, Tuo P, Meng Z, Jiang B, Yuan Y, et al. Downregulation of C1R promotes hepatocellular carcinoma development by activating HIF‐1α‐regulated glycolysis. Molecular Carcinogenesis. 2024;63(11):2237-2253. doi:10.1002/mc.23806

BibTeX
@article{Ma2024,
  author = {Ma, Yuying and Wang, Yuehua and Tuo, Peng and Meng, Zhongji and Jiang, Bin and Yuan, Yahong and Ding, Yan and Naeem, Abid and Guo, Xingrong and Wang, Xiaoli},
  title = {Downregulation of C1R promotes hepatocellular carcinoma development by activating HIF‐1α‐regulated glycolysis},
  journal = {Molecular Carcinogenesis},
  year = {2024},
  volume = {63},
  number = {11},
  pages = {2237--2253},
  doi = {10.1002/mc.23806}
}
Kostenlos starten →